ERBB2 and breast cancer: Our result is in contrast with a recently published observation by Pantelimon et al. demonstrating that patients diagnosed with aggressive tumors subtypes (HER2-positive and TNBC) had a significantly higher BMI than luminal-type BC patients [50].